Showing results (31-40 of 697) with videos related to

Sort By:
Pageof 70
Blut|December 1, 1990
Why clinicians should be interested in interleukin-3P Valent, K Geissler, C Sillaber, et al.
European Journal of Haematology|August 1, 1989
Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failureM Hinterberger-Fischer, P Höcker, K Lechner, et al.
International Journal of Cardiology|November 1, 1990
Prognostic role of inducible ventricular tachycardia in patients with dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardiaH D Gössinger, M Jung, L Wagner, et al.
Annals of Hematology|June 10, 1998
Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AMLM Mitterbauer, R Kusec, I Schwarzinger, et al.
Onkologie|April 1, 1986
[Lineage infidelity of leukemia cells]P Bettelheim, U Köller, O Majdic, et al.
Annals of Hematology|July 1, 1993
Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon alpha therapy of neutropenic patients with hairy cell leukemiaC Lorber, A Willfort, L Ohler, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Interleukin 3 activates human blood basophils via high-affinity binding sitesP Valent, J Besemer, M Muhm, et al.
Blood|June 1, 1982
Glycosylated hemoglobins (GHb): an index of red cell survivalS Panzer, G Kronik, K Lechner, et al.
Bone Marrow Transplantation|January 23, 1999
Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemiaE Reiter, H T Greinix, S Brugger, et al.
American Journal of Hematology|March 1, 1987
Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentratesI Schwarzinger, I Pabinger, C Korninger, et al.
Pageof 70